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Context, aims and objectives: As many as half of all patients with chronic conditions are using 
their medicines in a way that is not fully effective, resulting in sub-optimal treatment and 
subsequent increases in hospitalisations and emergency department visits. High levels of 
inappropriate prescribing further compound this problem. These issues are especially germane 
to older patients. Safe and effective pharmacotherapy remains one of the greatest challenges 
in this population, where models of healthcare delivery lag behind the enormous growth in 
single disease focused pharmacotherapy. The implications for safe, efficient, effective and 
sustainable deployment of healthcare resources are significant from both a healthcare 
systems and societal perspective. 
Integrated care models have the potential to mitigate inappropriate polypharmacy, while 
simultaneously diminishing problems related to poor adherence. Project SIMPATHY addresses 
both of these issues by aiming to stimulate and support innovation throughout the European 
Union regarding the management of polypharmacy and adherence in the older patient. The 
SIMPATHY Consortium has completed case studies in eight EU countries, providing useful 
insights into how different health care systems address this challenge. This workshop will 
present these findings, using them as a basis for discussion on the practicalities of integrating 
new practices into existing workflow, highlighting the opportunities that an integrated care 
model can provide. 
Target participants: Policymakers, health system administrators, managers, clinicians 
Proposed structure and timing: What do we mean when we say polypharmacy? How does it 
apply to me? 
Alpana Mair; Deputy Chief Pharmaceutical Officer for Scotland, Healthcare Quality and 
Strategy Directorate, Scottish Government Health Department 
Medicines management should be a key component of integrated care, affecting nearly all 
providers in all settings, and is paramount in the older population. However, health care 
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providers are often faced with problems related to inappropriate management of 
polypharmacy and poor adherence by patients. 
This presentation will introduce the audience to the concept of polypharmacy and adherence, 
its importance, and what tools and evidence already exist to create solutions. 
Looking at Europe: A diverse and emerging picture of polypharmacy 
Jennifer McIntosh; Research Scientist at Hospital Clinic Barcelona / FCRB 
Building on original research undertaken by the SIMPATHY Consortium, a picture of current 
policies around polypharmacy in Europe has emerged. The picture is complex, with multiple 
economic, social, and cultural factors explaining the development of these programmes. The 
details of this picture provide a strong foundation for the development of future policies for 
appropriate management of polypharmacy. 
This presentation will detail the findings of 8 European case studies, showcasing current 
approaches polypharmacy management. 
_(Important: The details of each case study will be presented in a set of 8 posters that will be 
submitted to the conference by each institution carying out the work)_ 
Scaling up polypharmacy management: The Scottish success story 
Alpana Mair; Deputy Chief Pharmaceutical Officer for Scotland, Healthcare Quality and 
Strategy Directorate, Scottish Government Health Department 
Implementing a new programme into existing practice is one of the most challenging aspects 
of creating integrated health care systems. The Scottish National Health Service has achieved 
this by successfully developing and implementing a comprehensive polypharmacy management 
policy throughout their healthcare system. This programme has become a model on an 
international level, and is currently a reference point for the development of European wide 
policies to address polypharmacy in the elderly. 
This presentation will describe the rationale that prompted the development of the Scottish 
programme, unique features of the programme including leveraging national level patient data 
to identify patients at risk for inappropriate polypharmacy, and management strategies that 
facilitated the integration of the programme into daily practice on a wide scale.  
Polypharmacy and teamwork: The Catalan multidisciplinary experience 
Carles Codina; Head of Pharmacy Department at Hospital Clínic Barcelona - Consorci 
Hospitalari de Vic 
Núria Molist; physician at the Acute Geriatrician Unit Consorci Hospitalari de Vic - Hospital 
Santa Creu de Vic 
Introducing new practices requires champions, especially in complex institutions. Although 
multidisciplinary teams are becoming the functional decision making unit, their 
implementation requires support from multiple stakeholders. Pharmacists in particular have a 
central role to play on these teams in developing a new understanding about the importance 
of appropriate polypharmacy management. 
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This presentation will describe the development and implementation of a patient centred 
multidisciplinary care team, highlighting the role both the pharmacy and geriatric medicine 
departments played in creating a successful and sustainable programme. 
Facilitated discussion 
Albert Alonso (moderator); Innovation Directorate at Hospital Clínic Barcelona 
This work has been supported by the SIMPATHY project, grant agreement number 663082, co-
funded by the European Commission CHAFEA Health Program 
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